Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exponent (EXPO) Asset Writedowns and Impairment: 2010-2025

Historic Asset Writedowns and Impairment for Exponent (EXPO) over the last 13 years, with Oct 2025 value amounting to $1.5 million.

  • Exponent's Asset Writedowns and Impairment rose 93.47% to $1.5 million in Q4 2025 from the same period last year, while for Oct 2025 it was $3.4 million, marking a year-over-year decrease of 23.51%. This contributed to the annual value of $4.5 million for FY2025, which is 37.98% up from last year.
  • Per Exponent's latest filing, its Asset Writedowns and Impairment stood at $1.5 million for Q4 2025, which was up 357.88% from $330,000 recorded in Q3 2025.
  • Over the past 5 years, Exponent's Asset Writedowns and Impairment peaked at $1.5 million during Q4 2025, and registered a low of -$297,000 during Q1 2021.
  • For the 3-year period, Exponent's Asset Writedowns and Impairment averaged around $888,364, with its median value being $892,000 (2023).
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first soared by 356.23% in 2021, then crashed by 79.98% in 2025.
  • Exponent's Asset Writedowns and Impairment (Quarterly) stood at $761,000 in 2021, then grew by 27.33% to $969,000 in 2022, then skyrocketed by 35.60% to $1.3 million in 2023, then grew by 24.96% to $781,000 in 2024, then spiked by 93.47% to $1.5 million in 2025.
  • Its Asset Writedowns and Impairment was $1.5 million in Q4 2025, compared to $330,000 in Q3 2025 and $256,000 in Q2 2025.